[Immunoreactive urinary thromboxane B2 in experimental mesenteric thrombosis in dogs]

Rev Invest Clin. 1989 Apr-Jun;41(2):123-7.
[Article in Spanish]

Abstract

Thromboxane B2 (TxB2) the stable metabolite of thromboxane A2 may be released as a response to ischemia. With the aim of investigating its role as an early diagnostic test in mesenteric thrombosis, immunoreactive TxB2 was measured in urine aliquotes in six sham operated dogs, nine dogs subjected to superior mesenteric artery ligation, and twelve dogs with superior mesenteric vein ligation. One hour urine volumes were collected before surgery and during the eight hours after the experimental procedures, and urinary osmolarities were also determined in each sample. Basal TxB2 levels were comparable in all groups. Although all groups showed a significant and rapid (one hour) increase in TxB2 as a response to surgery, in the controls it returned to normal after six hours, whereas in the rest a continuously increased production persisted throughout the study period. There was no difference in t-test comparisons depending on the sort of thrombosis. In spite of the urinary dilution induced during the study, a persistent increase in TxB2 excretion was found. We conclude that urinary TxB2 levels could prove useful in the early diagnosis of mesenteric ischemia.

Publication types

  • English Abstract

MeSH terms

  • Acute Disease
  • Animals
  • Biomarkers / urine
  • Dogs
  • Intestines / blood supply*
  • Ischemia / diagnosis*
  • Ischemia / urine
  • Mesenteric Arteries
  • Mesenteric Vascular Occlusion / diagnosis*
  • Mesenteric Vascular Occlusion / urine
  • Mesenteric Veins
  • Radioimmunoassay
  • Thrombosis / diagnosis*
  • Thrombosis / urine
  • Thromboxane B2 / urine*

Substances

  • Biomarkers
  • Thromboxane B2